Invitation to Roche ’s Half Year Results 2023 Webinar

 Roche will publish its Half Year Results of 2023 prior to the opening of the Swiss Stock Exchange onThursday, 27 July 2023. 07:00 CEST / 06:00BST / 01:00 AM EDT / 10:00 PM PDT (evening before)Release will be e-mailed and posted on the Roche IR website>click herePresentation slides will be posted on the Roche IR website>click here 14:00 – 15:30 CEST / 13:00 – 14:30 BST08:00 – 09:30 AM EDT / 05:00 - 06:30 AM PDTThe webinar will start with presentations by senior management,followed by a Q&A session.Presenters:Thomas Schinecker, CEO Roche GroupTeresa Graham, CEO Roche PharmaceuticalsMatt Sause, CEO Roche DiagnosticsAlan Hippe, Chief Financial and IT Officer  We would like to invite all interested parties to participate in the webinar and to pre-register for the eventhere*Should you be unable to register for the webinar due to your company IT policy, please send an e-mail [e-mail].  A replay of the webcast will be available via>ir.roche.com*privacy notice  Best regards,   Bruno EschliHead of Investor Relations  Roche Investor Relations Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. SabineBorngr äberPhone: [phone]e-mail:[e-mail] Dr. BirgitMasjostPhone: [phone]e-mail:[e-mail] Dr. Gerard TobinPhone: [phone]e-mail:[e-mail]  Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail]  

Source: Roche Investor Update - June 27, 2023 Category: Pharmaceuticals Source Type: news